Nurix Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/13/2025 | 10.63 M | $200.35 M | 1,711.93% | 14.61% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.68 M | $144.61 M | 6.88% | 11.44% |
| REDMILE GROUP, LLC | 02/14/2025 | 4.19 M | $78.99 M | -2.06% | 6.25% |
| VANGUARD GROUP INC | 02/11/2025 | 4.35 M | $81.86 M | 8.31% | 5.97% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 3.88 M | $73.14 M | 0.00% | 5.78% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 3.59 M | $67.57 M | 3.00% | 4.93% |
| COMMODORE CAPITAL LP | 02/14/2025 | 3.00 M | $56.52 M | 81.82% | 4.47% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 3.00 M | $56.52 M | -22.44% | 4.47% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.01 M | $56.66 M | -2.01% | 4.13% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 2.38 M | $44.85 M | -6.58% | 3.55% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 2.10 M | $39.62 M | 97.29% | 3.13% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.77 M | $33.33 M | -1.10% | 2.64% |
| ARK INVESTMENT MANAGEMENT LLC | 02/04/2025 | 1.53 M | $28.83 M | -30.95% | 2.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.59 M | $29.87 M | 9.47% | 2.18% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.33 M | $25.12 M | 100.00% | 1.99% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.28 M | $24.11 M | -0.46% | 1.91% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 940,083 | $17.71 M | 9.26% | 1.40% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 872,959 | $16.45 M | 100.00% | 1.30% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/28/2025 | 789,222 | $14.87 M | 42.65% | 1.18% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/10/2025 | 789,222 | $14.87 M | 42.82% | 1.18% |
| CANDRIAM S.C.A. | 02/07/2025 | 634,626 | $11.96 M | -40.24% | 0.95% |
| WASATCH ADVISORS LP | 02/13/2025 | 599,401 | $11.29 M | -15.38% | 0.89% |
| 02/14/2025 | 563,067 | $10.61 M | 100.00% | 0.84% | |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 532,172 | $10.03 M | 21.23% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 572,834 | $10.79 M | 11.94% | 0.79% |
| SAMLYN CAPITAL, LLC | 02/14/2025 | 515,840 | $9.72 M | -9.23% | 0.77% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 531,197 | $10.01 M | -37.85% | 0.73% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 485,000 | $9.14 M | 14.12% | 0.72% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 506,839 | $9.55 M | 1.05% | 0.70% |
| PATIENT SQUARE CAPITAL LP | 02/14/2025 | 446,296 | $8.41 M | 36.99% | 0.66% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 437,772 | $8.25 M | 24.85% | 0.65% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 463,469 | $8.73 M | -9.69% | 0.64% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 402,955 | $7.59 M | 13.32% | 0.60% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 424,137 | $7.99 M | 91.30% | 0.58% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 378,500 | $7.13 M | -9.88% | 0.56% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 409,637 | $7.72 M | -39.18% | 0.56% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 374,673 | $7.06 M | 108.15% | 0.56% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 353,471 | $6.66 M | 64.61% | 0.53% |
| WOODLINE PARTNERS LP | 02/14/2025 | 338,462 | $6.38 M | 0.47% | 0.50% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 330,614 | $6.23 M | 100.00% | 0.49% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 314,762 | $5.93 M | 0.00% | 0.47% |
| BESSEMER GROUP INC | 02/13/2025 | 306,003 | $5.77 M | -0.02% | 0.46% |
| NORGES BANK | 02/12/2025 | 318,800 | $6.01 M | 100.00% | 0.44% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 290,000 | $5.46 M | -3.33% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 288,000 | $5.43 M | 366.77% | 0.40% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 250,000 | $4.71 M | 25.00% | 0.37% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 232,000 | $4.37 M | -20.00% | 0.35% |
| WESTHILL FINANCIAL ADVISORS, INC. | 01/31/2025 | 228,333 | $4.30 M | -4.20% | 0.34% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 190,905 | $3.60 M | 8.92% | 0.26% |
| FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 168,762 | $3.18 M | 1.66% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nurix Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 213 institutional investors and hedge funds held shares of Nurix Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 10.63 M
BlackRock Funding, Inc. /DE: 7.68 M
VANGUARD GROUP INC: 4.35 M
Redmile Group, LLC: 4.19 M
BAKER BROS. ADVISORS LP: 3.88 M
WELLINGTON MANAGEMENT GROUP LLP: 3.59 M
120.85% of Nurix Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 94.72 M shares in the last 24 months. This purchase volume represents approximately $1.82 B in transactions.